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ABSTRACT 
Human cytomegalovirus (HCMV) latency 
and reactivation relies on a complex 
interplay between cellular differentiation, 
cell signaling pathways, and viral gene 
functions. HCMV reactivation in dendritic 
cells (DCs) is triggered by interleukin-6 
(IL-6) and extracellular signal–regulated 
kinase (ERK)–mitogen-activated protein 
kinase (MAPK) signaling. However, 
activation of the same pathway fails to 
reactivate HCMV in other myeloid cell 
types, despite this signaling axis being 
active in those cells. We hypothesized that 
IL-6–induced ERK activation initiates the 
changes in chromatin structure required 
for viral reactivation, but that a 
concomitant signal is necessary to 
complete the changes in chromatin 
structure required for gene expression to 
occur. Using a differential 
phosphoproteomic approach in cells that 
do or do not support IL-6–induced viral 
reactivation, we identified the concomitant 
activation of a Src family kinase (SFK), 
hematopoietic cell kinase (HCK), 
specifically in DCs in response to IL-6. 
Pharmacological and genetic inhibition of 
HCK activity indicated that HCK is 
required for HCMV reactivation. 
Furthermore, the HCK/SFK activity was 
linked to the recruitment of the monocytic 
leukemia zinc finger protein (MOZ) 
histone acetyltransferase to the viral 
promoter, which promoted histone 
acetylation after ERK-mediated histone 
phosphorylation. Importantly, 
pharmacological and genetic inhibition of 
MOZ activity prevented reactivation. 
These results provide an explanation for 
the selective activation of viral gene 
expression in DCs by IL-6, dependent on 
concomitant SFK and ERK signaling. 
They also reveal a previously unreported 
role for SFK activity in the regulation of 
chromatin structure at promoters in 
eukaryotic cells via MOZ histone 
acetyltransferase activity.  
 
 
The regulation of eukaryotic gene 
expression requires the co-ordinated action 
of a number of molecular mechanisms 
active within the cell. One key mechanism 
is the selective activation of cellular 
signalling pathways to either activate or 
repress gene expression in response to cell 
stimulation (1). It is noteworthy that a 
major contribution to the regulation of 
20,000+ human genes is dependent on a 
relatively small number of canonical 
signalling pathways (2). Thus how such 
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complex patterns of gene regulation are 
performed by a limited number of 
pathways is an area of great interest. The 
key players in these pivotal signalling 
pathways have, largely, been identified 
and characterised (2). Thus, even more 
prescient is the question of how a 
particular pathway can evoke different 
effects depending on the stimulus and cell 
type it is being activated in (1). This alone 
suggests that the molecular and cellular 
context in which the pathway is being 
activated is critical for dictating the final 
output of the effector function. 
 
We consider this problem through studies 
of HCMV reactivation. Lifelong latent 
HCMV infections are established in the 
CD34+ haematopoietic progenitor cells 
where a pivotal event is the silencing of 
lytic viral gene expression - with the 
regulation of the major immediate early 
promoter (MIEP) hypothesised to be a 
critical determinant (3-6). Consequently, a 
key first step towards reactivation is the 
induction of major IE gene expression 
from this previously silenced promoter and 
thus research has focused on the factors 
regulating this. This has led to a consensus 
that cellular differentiation of naturally 
latent HCMV CD34+ cells or monocytes 
is pivotal for robust reactivation (5-13). 
Furthermore, reactivation driven by 
cellular differentiation is augmented by 
inflammatory cytokine signalling 
supporting key roles for cellular signalling 
(5,8,14,15). It is likely that this is multi-
faceted with ERK-MAPK, cAMP and 
EGFR/Pi3K signalling implicated in 
HCMV reactivation from latency in a cell 
and model specific manner (8,16-19). 
What is consistent is that reactivation is 
largely dependent on cellular mechanisms 
of gene regulation through the 
complimentary mechanisms of mimicry 
(the MIEP bears the hallmarks of an 
inflammatory promoter (20)) and direct 
viral regulation (e.g. UL135/UL138 
antagonism and EGFR (17)). Ultimately, 
the HCMV genome is regulated by higher 
order chromatin structure and, essentially, 
can be considered another eukaryotic 
genetic unit for the purpose of regulatory 
studies. 
 
Here we now show that ERK-MAPK 
driven reactivation of HCMV viral gene 
expression is dependent on the 
concomitant activation of src family 
kinase (SFK) signalling in monocyte 
derived dendritic cells (MoDCs). We link 
this to the activation of SFK member 
haematopoietic cell kinase (HCK) which is 
highly expressed in cells that support 
reactivation and, consequently, its deletion 
from cells is sufficient to abrogate 
reactivation. Through molecular studies 
we show for the first time that SFK 
signalling can drive histone acetylation 
and does this, in part, via the recruitment 
of the histone acetyltransferase MOZ to 
the MIEP. Thus SFK activity works post 
ERK-MAPK signalling to potentiate an 
open chromatin structure ensuring 
reactivation proceeds post exit from 
latency.  
 
RESULTS 
IL-6 promotes increased 
phosphorylation of Src family kinases in 
MoDCs 
We have previously observed that IL-6-
ERK-MAPK signalling promotes HCMV 
reactivation in MoDCs but not 
undifferentiated progenitors (8) and, 
consistent with this, delivery of a 
dominant negative version of the ERK1/2 
kinase MEK1 (thus an inhibitor of 
ERK1/2 activation) inhibits reactivation 
(16). Thus our first experiments tested the 
reciprocal experiment – the delivery of a 
constitutively active version of MEK1. 
The data showed the activation of ERK by 
delivery of a constitutively active version 
of MEKK does not trigger the full 
induction of viral IE gene expression (Fig. 
1a) despite evidence of increased ERK 
phosphorylation in the cells (Fig. 1b). 
This, in the context of our previous results, 
suggested the activation of ERK alone was 
not sufficient for the induction of viral 
gene expression 
 
To investigate this further we took 
advantage of a previous study we had 
performed in which we demonstrated that 
if we altered the culture conditions and 
promoted the monocytes to differentiate 
into immature monocyte derived 
Langerhans-like cells (MoLCs)  they did 
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not support IL-6 induced reactivation 
unlike observed in MoDCs (21). This 
suggested that the pathway of 
differentiation was playing an important 
role in the reactivation phenotype. 
However, an analysis of MoLCs 
demonstrated that they were clearly IL-6 
responsive such that IL-6 promoted ERK 
phosphorylation in MoLCs (Fig. 1c) which 
was consistent with the observation that 
both MoDCs and MoLCs express similar 
levels of the IL6 receptor on their cell 
surface (Fig. 1d). All these observations 
suggested the intracellular context in 
which IL-6 was activating ERK could be 
important.  
 
Thus we decided to investigate whether 
IL-6 was concomitantly activating 
additional pathways in MoDCs that could 
explain the differential reactivation 
phenotype between the two cell types. To 
do this a comparative phospho-proteomics 
of IL-6 stimulated MoLCs and MoDCs 
was performed (Fig. 1e, Fig S1). This 
confirmed that MoLCs were responsive to 
IL-6 with evidence of both ERK and Stat 
activation detected (Fig. S1). Although the 
pattern of phosphorylation was broadly 
similar, a number of differences in protein 
phosphorylation profiles were observed 
between the two cell types in response to 
IL-6 (Fig. 1f, Fig. S1). We noted that the 
biggest changes in protein phosphorylation 
were observed with two SFKs, HCK and 
src itself and thus we investigated this 
family of kinases further. 
 
SFK activity is required for chromatin 
remodelling in response to IL-6 
To demonstrate whether SFK activity was 
important for HCMV reactivation we 
tested the impact of SFK inhibitors on 
HCMV reactivation from latency. Pre-
treatment of latently infected MoDCs with 
SFK inhibitors prior to IL-6 was sufficient 
reduce IL-6 induced IE gene expression 
from both experimental and natural 
latency when analysed 16hrs post 
stimulation (Fig. 2a,c). No comparable 
impact on IE gene expression was evident 
in primary infection of MoDCs or 
fibroblasts (Fig. S2) nor was IL-6 induced 
expression of c-fos mRNA affected in 
reactivating MoDCs (Fig. 2b) suggesting 
that a pan inhibition of IL-6 responsive 
genes was not occurring and, furthermore, 
the requirement for SFK activity to drive 
viral IE gene expression was restricted to 
latency and reactivation. 
 
Unlike src, which is expressed in most 
cells, HCK expression is restricted to 
haematopoietic cells (22). Coupled with 
the observation that HCK expression was 
higher in myeloid cells that support 
HCMV reactivation (Fig. 2d) we chose to 
investigate HCK further. Using siRNAs, 
we transiently depleted HCK from MoDCs 
(Fig. 2e). A loss of HCK resulted in a clear 
decrease of IE gene expression in response 
to IL-6 (Fig. 2f). Again, the impact on IE 
RNA did not reflect a global shutdown of 
IL-6 induced gene expression as a number 
of other IL-6 responsive genes were 
relatively unaffected in the HCK KD cells 
(Fig. 2g). Thus HCK activity was an 
important component of the SFK induced 
reactivation of HCMV and was having a 
particularly strong impact on HCMV gene 
expression in MoDCs. 
 
The observed inhibition of IE gene 
expression in our studies suggested 
SFK/HCK activity was particularly 
important during the initial stages 
reactivation – when a key viral promoter 
(the Major immediate early promoter 
(MIEP)) must be activated. An important 
mechanism of regulation at the MIEP 
involves the activity of higher order 
chromatin structure (6,16,23,24). Most 
recently, we have linked changes in 
chromatin structure required for 
reactivation with ERK driven activation of 
cellular kinases, mitogen and stress 
activated kinases, which promote histone 
phosphorylation at the MIEP in a CREB 
transcription factor dependent manner in 
MoDCs (16). Indeed, this concept of 
histone phosphorylation for reactivation of 
viral gene expression is an emerging 
theme in herpes virology (25,26).  
 
Given the importance of chromatin in viral 
reactivation we asked what, if any, impact 
SFK inhibitors had on the chromatin 
phenotype at the MIEP (Fig. 3). As 
expected, in reactivating MoDCs 
stimulated with IL-6 histone H3-S10 
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phosphorylation and H3-K14 acetylation 
predominated at the reactivating MIEP and 
was concomitant with a reduction in H3-
K9 methylation (Fig. 3a). In contrast, at 2 
hours post IL-6 in the presence of the SFK 
inhibitor, PP2, the chromatin phenotype 
copied the latent MIEP phenotype prior to 
IL-6 addition (Fig. 3a). This suggested that 
SFK activity could be co-involved in H3-
S10 phosphorylation with ERK. 
 
However, an analysis of the MIEP at 
earlier time-points revealed that at 30 
minutes post IL-6 H3-S10 phosphorylation 
at the MIEP was evident even in PP2 
treated cells despite being reversed by two 
hours (Fig. 3b). This transient H3-S10 
phosphorylation was concomitant with the 
loss of HP1 from the MIEP (Fig. 3c) – H3-
S10 phosphorylation has been 
hypothesised to promote HP1 dissociation 
from methylated histones (27). Indeed, 
few differences in chromatin phenotype at 
the MIEP were observed between control 
and PP2 treated MoDCs at 30 minutes 
except histone H3-K14 acetylation was 
reduced (Fig. 3d,e). This suggested a 
model whereby ERK was initiating 
chromatin modifications at the MIEP but 
additional cellular signalling (i.e. SFK 
signalling) was required to potentiate the 
effects post ERK.   
 
The MOZ histone acetyltransferase 
promotes HCMV reactivation in a SFK 
dependent manner 
To test the hypothesis that ERK was 
important for initiating reversal of the 
chromatin phenotype but the effect was 
potentiated by SFK activity we sought to 
identify the identity of the histone 
acetyltransferase responsible for HCMV 
reactivation – since this would likely be 
involved at the MIEP post ERK-mediated 
histone phosphorylation.  
 
Although the focus of our study is on 
HCMV reactivation in MoDCs we chose 
to include an analysis of reactivation in 
macrophage-like cells to test whether the 
same HAT was responsible in multiple 
cell types that support HCMV 
reactivation.In order to dothis we used 
pharmacological inhibitors of cellular 
HAT activity in two models of HCMV 
reactivation: our MoDC model and also 
the THP1 macrophage model. In the THP1 
model cell line we observed that MG149 
(an inhibitor of MOZ and Tip60 HATs) 
reduced IE gene expression (Fig. S3a). A 
titration of the MYST family inhibitor 
MG149 (which has different activities 
dependent on concentration) and the 
relative inability of a Tip60-specific 
inhibitor (NU9056) to inhibit IE gene 
expression suggested that MOZ was the 
HAT most important for reactivation in 
THP1 cells (Fig. S3b). Interestingly, in the 
MoDC model the phenotype was different. 
In these cells, both inhibitors of p300 
(C646) and MYST family HATs (MG149) 
had the biggest impact on IE gene 
expression (Fig. 4a). Again, a titration of 
MG149 alongside a lack of activity of 
NU9056 suggested that it was MOZ, and 
not Tip60, that was important for 
reactivation in MoDCs (Fig. 4b). 
Furthermore, the failure of CPTH2 and 
NU9056 to prevent reactivation was not 
due these inhibitors reducing histone 
acetylation in cells (Fig. 4c).  However, 
the data using C646 also suggested that 
p300 activity appeared to be more 
important for reactivation in the MoDC 
model - in contrast with the THP1 
macrophage cell line where very little 
impact was observed with C646 (Fig. S3). 
This MoDC specific impact on 
reactivation with the C646 could be re-
capitulated with an inhibitor of the 
transcription factor, CREB (66615) – a 
known interaction partner of p300 (Fig. 
S4). Specifically, 66615 inhibited 
reactivation in MoDCs but not THP1 cells 
(Fig. S4a) despite 66615 being active in 
the THP1 cell line (Fig. S4b).    
 
For the purpose of this study we chose to 
focus on the suggestion that MOZ activity 
was centrally important in both models of 
HCMV latency and reactivation tested. 
However, although the pharmacological 
data argued for a role for MOZ we sought 
to confirm this genetically prior to further 
investigation of the impact of MOZ on 
HCMV reactivation. To do this, MoDCs 
were transfected with MOZ targeted 
siRNAs or a non-targeting control and 48 
hours later reactivation stimulated with IL-
6. The data demonstrate that the depletion 
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of MOZ from DCs (Fig. 4d) was sufficient 
to reduce viral IE gene expression in 
response to IL-6 (Fig. 4e) and thus 
pharmacological and genetic depletion of 
MOZ activity in MoDCs was sufficient to 
prevent HCMV reactivation.  
 
The demonstration that MOZ was 
important for reactivation did not 
determine whether the effects were direct 
or indirect. To begin to address this we 
utilised ChIP analyses to demonstrate that 
MOZ was bound to the MIEP during the 
early stages of viral reactivation arguing 
that it played a direct role in the regulation 
of IE gene expression (Fig. 5a). 
Furthermore, pre-treatment with the SFK 
inhibitor PP2 prevented the recruitment of 
MOZ to the MIEP suggesting that 
activation of SFK signalling was driving 
the recruitment of MOZ (Fig. 5a). 
Consistent with MOZ binding being 
important for histone modifications 
occurring at the MIEP during reactivation 
it was demonstrated that the acetylation of 
histone H4 at the MIEP was markedly 
reduced in MG149 treated cells at 2 hours 
post IL-6 (Fig. 5b). Furthermore, it was 
clear from the analyses that histone de-
methylation or prolonged histone 
phosphorylation were only partially 
impaired suggesting these events preceded 
or were independent of MOZ activity (Fig. 
5b). 
 
DISCUSSION 
These data reinforce the view that HCMV 
reactivation is highly dependent on 
cellular mechanisms of gene regulation. 
Furthermore, they demonstrate a novel 
role for SFK signalling in the control of 
gene expression via chromatin 
modifications. Specifically, we show that 
ERK-MAPK driven HCMV reactivation is 
dependent on the concomitant activation 
of SFK signalling in response to IL-6. A 
key event for reactivation is the 
availability and activation of HCK – a 
haematopoietic cell specific kinase that is 
up-regulated upon myeloid DC 
differentiation. In light of our current data 
we propose a model whereby SFK activity 
works post ERK-mediated histone 
phosphorylation to support the transition 
of the MIEP to a fully open chromatin 
state to ensure robust IE gene expression 
and, ultimately, viral reactivation. 
Furthermore, we propose this dependence 
on SFKs is linked with a role in the 
recruitment of the MOZ HAT activity to 
the MIEP to drive chromatin modifications 
conducive for transcription. 
 
The data emphasise how cell signalling 
and the regulation of eukaryotic gene 
expression are highly context-specific. 
ERK-MAPK activity can drive HCMV 
reactivation (8,16) yet what we now show 
is that it is the context within which the 
ERK pathway is activated is important. 
Specifically, ERK is only pro-reactivation 
when additional signalling, and 
specifically HCK, is activated at the same 
time by IL6. What became evident was 
that this concomitant signalling pathway 
activation by IL6 was most effective in the 
MoDCs providing a model for the 
differential regulation of gene expression 
in a cell type specific manner.  
 
An important role for cell identity also 
resonated with attempts to identify the 
HAT responsible for HCMV reactivation – 
which again had elements of cell specific 
responses. For instance, a role for p300 
would be consistent with the known 
interaction of this protein with 
phosphorylated CREB (28)– a factor we 
have reported to be required for the 
efficient reactivation of HCMV in 
response to IL-6 in MoDCs (16). Indeed, it 
was of note that the C646 inhibitor 
phenotype was re-capitulated with the 
CREB transcription factor inhibitor 
(66615) suggesting that an interaction 
between these two proteins was driving 
the MoDC reactivation phenotype. In 
contrast, the C646 data suggest that p300 
activity is less important in the THP1 
macrophage model where instead MOZ 
activity appeared to be sufficient. A likely 
explanation is that activation of the MIEP 
in the THP1 model is via the activation of 
different pathways which is dictated by the 
stimuli used for reactivation. For instance, 
multiple members of the MYST family of 
HATs including Tip60 and MOZ interact 
with the NF-kB pathway (29,30). The 
phorbol ester used to promote THP1 
differentiation is a potent activator of NF-
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kB dependent transcription (31) which 
may be sufficient in macrophage like cells 
to reactivate HCMV. Thus the virus has 
evolved to utilise different transcription 
and signalling pathways to facilitate 
reactivation in multiple myeloid cell types 
in response to a number of different 
ligands.   
 
However, the role of MOZ as a player in 
both cell types suggests that common 
events to both are required. MOZ histone 
acetyltransferase activity is heavily 
implicated in the haematopoietic stem cell 
(HSC) differentiation processes to which 
HCMV reactivation is tied (32).  Pertinent 
for our studies, MOZ has been shown to 
target lysine residues 9 and 14 on H3 for 
acetylation (32) and also histone H4 which 
is heavily acetylated when bound to the 
MIEP in reactivating cells (6). Lysine 9 
methylation is a major driver of HP1 
recruitment, the binding of which is also 
correlated with the regulation of the MIEP 
(6,33). Furthermore, H3-K9 modifications 
are closely tied with the nearby acetylation 
of H3-K14 residues. Indeed, here we 
observe that inhibition of SFK activity 
results in a failure to reverse H3-K9 
methylation and promote H3-K14 
acetylation – potentially providing a link 
between SFKs, MOZ and HCMV 
reactivation. Furthermore, the requirement 
for MOZ activity in both models may 
reflect a combinatorial role in HAT 
activity. Indeed, activation of AML1 
transcriptional activity has been shown to 
involve MOZ and p300 acting co-
operatively to enhance AML1 function 
and thus a similar model may be at play 
here (34).  
 
Another aspect of the analogy to AML1 
also interesting is that MOZ activity has 
been linked to the development of Acute 
Myeloid Leukaemia (AML) – whereby the 
MOZ gene translocates to generate gene 
fusions with other transcriptional 
regulators (including p300) (34,35). Some 
studies show that AML patients with 
HCMV have better clinical outcomes. 
Although the mechanistic basis for this not 
understood one hypothesis is that the 
tumour cells express CMV antigens that 
promote immune clearance. Potentially, 
the over-activation of MOZ in that could 
occur in some AML cells (depending on 
the genetic basis of the gene fusion (35)) 
and elevated activity on the MIEP is 
driving this surprising benefit of HCMV 
infection through production of more IE 
antigen targets for T cells or indirectly by 
promoting recruitment of cytotoxic T cells 
to the tumour environment. 
 
This study has focused on cellular 
mechanisms of regulation not addressing 
the contribution of latent viral functions. 
However US28, another latently expressed 
gene product, has the capacity to have a 
profound effect on cell signalling 
pathways in a cell type specific manner 
(36). Many of these pathways have already 
been implicated in the regulation of the 
MIEP including ERK, MSK, NF-kB and, 
most recently, cFos (37,38). Notably, two 
other prominent hits in one study were src 
and HCK – with US28 enhancing their 
phosphorylation during latent infection 
(37). If activatory, then how this is 
reconciled with a role for HCK in 
reactivation is not clear. It is possible that 
the phosphorylation was inhibitory and 
thus it could be a case of US28 turning 
them off. Alternatively, it could suggest 
that the pathway by which HCK is 
activated is crucial – HCK can be 
activated via TLR4 or CD45 signalling at 
the plasma membrane or via gp130 
activation by IL-6 and, pertinently, the 
mechanism of Hck activation can result in 
quite different outputs downstream of Hck 
in the same cells (22). US28 is a 
membrane bound protein (36) and thus it 
could be hypothesised that activation via 
US28 is gp130 independent and, 
furthermore, the virus is commandeering 
Hck activity during latency for other 
functions. This could potentially deprive 
the cell of available Hck that can be 
activated by gp130 signalling in response 
to IL-6 in latent cells. However, given that 
MoDC differentiation promotes an 
increase in Hck expression it may suggest 
that increased availability of de novo Hck 
makes MoDCs more responsive to IL-6 in 
terms of HCMV reactivation.  
 
Taken together, these data further 
demonstrate through a study of viral gene 
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regulation how integrated signalling 
through multiple pathways promotes cell 
type and ligand specific gene expression 
and implicate a clear role for SFK activity 
in the recruitment and activity of 
chromatin modifying enzymes to 
promoters to differentially control gene 
expression. They also exemplify the 
benefit of studying how persistent viruses 
are dependent on these host pathways to 
complete their lifecycle as it provides a 
highly tractable tool to study the 
mechanisms of eukaryotic gene regulation. 
Importantly, they further demonstrate the 
dependence on host cell functions of 
pathogens which, in this case, may expose 
the virus to novel host targeted strategies 
to control the reactivation of this highly 
dangerous pathogen in immune suppressed 
patients.  
 
EXPERIMENTAL PROCEDURES 
 
Ethics Statement 
The collection of venous blood samples 
from anonymous donors was approved and 
performed in accordance with established 
guidelines for the handling and processing 
of said tissue by the UCL Local Research 
Ethics committee. All studies with human 
material abide by Declaration of Helsinki 
principles. 
 
Virus, cell lines, culture and reagents  
The clinical isolate Merlin (39) was 
purified from infected human retinal 
pigment epithelial cells using sorbitol 
gradients as previously described (40)(40). 
Viruses for these studies were 
characterised by their ability to infect 
primary dendritic cells to assay myelo-
tropism – routinely, virus preparations 
infected 10-20% DCs when used at an 
MOI of 5 calculated on fibroblasts. 
 
Primary CD14+ monocytes were isolated 
from the venous blood of anonymous 
donors who had given informed consent 
under the appropriate local rules. 
Typically, 50mls of venous blood was 
diluted in PBS either 1:1 separated on a 
ficoll gradient (Lymphoprep, Nycomed, 
Melville, NY). Labelled CD14+ positive 
cells (Miltenyi Biotec, Auburn, CA) were 
rescued using Magnet Activated Cell 
Sorting (MACS) and cultured in X-vivo 
15 (Cambrex, Walkersville, MD) 
supplemented with 2mM L-Glutamine and 
cytokines to promote DC differentiation 
where appropriate.  
 
Recombinant adenoviruses expressing 
constitutively active MEK1 and GFP were 
purchased and used directly without 
propagation at an MOI of 100 (Cell 
biolabs, San Diego, CA). 
 
Experimental infection of primary cells 
and differentiation 
CD14+ monocytes (5x105 cells/well) were 
infected in 250ul of X-vivo 15 media plus 
HCMV (MOI=5) for 3 hours then rescued 
in 1ml fresh media. After 3 days, 
experimentally infected CD14+ cells were 
differentiated to immature monocyte 
derived DCs (MoDCs) or immature 
monocyte derived Langerhans cells 
(MoLCs) as described previously (8,21). 
Briefly, CD14+ monocytes were cultured 
with Interleukin-4 (100ng/ml) and GM-
CSF (100ng/ml) for 6 days to promote 
differentiation to a MoDC phenotype or 
IL-4 (10ng/ml), GM-CSF (100ng/ml) and 
TGF-b (10ng/ml) for 2 days followed by a 
further 4 days with GM-CSF and TGF-b to 
promote a MoLC phenotype. Following 
culture, immature MoLCs and MoDCs 
were incubated with recombinant IL-6 
(500ng/ml). All cytokines were from 
Peprotech (Rocky Hill, NJ) unless 
otherwise stated.  
THP1 cells were cultured in RPMI 1640 
supplemented with 10% fetal bovine 
serum. To establish latent infections 
monocytes or THP1 cells were infected for 
3 hours with Merlin at MOI of 5 (based on 
HFF infectivity). Monocytes were left for 
3 days before differentiation into MoDCs. 
THP1 cells were left for 5 days before the 
addition of phorbol 12-myristate 13-
acetate (20ng/ml; SIGMA) for 24 hours 
trigger THP1 differentiation and HCMV 
reactivation.   
  
Inhibitors, antibodies and Chromatin 
Immunoprecipitation 
To test for inhibition of HCMV 
reactivation, inhibitors were added prior to 
IL-6 stimulation. MEK/ERK: U0126 (or 
inactive analogue U0124; Calbiochem, 
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both 10uM), SFK: PP2 (SIGMA) or 
PP121 (Santa Cruz Biotechnology; both 
20nM), p300: C646 (SIGMA; 25uM), 
MYST family: MG149 (Axon Medchem; 
75uM), Gcn5: CPTH2 (SIGMA; 100uM), 
Tip60: NU9056 (Tocris; 10uM), MOZ: 
MG149 used at 25uM as directed by 
manufacturer. CREB: 666-15 
(Calbiochem) was used at 1uM in DMSO. 
 
For Western blotting rabbit anti-p42/p44 
or rabbit anti- phosphor-p42/p44 
antibodies (ERK) or rabbit anti-GAPDH 
(1:1,000, Abcam) were used followed by 
HRP conjugated goat anti-rabbit antibody 
(1:4000; Santa Cruz Biotechnology, Santa 
Cruz, CA). To analyse histone 
modifications by Western blot an anti-
acetylated lysine 14 H3 rabbit antiserum 
(Millipore, 1:1000 dilution) or rabbit anti-
histone H3 antibody (Millipore, 1:1000 
dilution) was used and detected as per 
ERK above.    
For ChIP studies DCs were fixed with 1% 
formaldehyde (10 mins) and then prepared 
for ChIP using enzymatic digestion kit as 
described by manufacturer (Chromatin 
Prep Module, ThermoFisher Scientific). 
DNA fragments associated with histones 
was immunoprecipitated with rabbit IgG 
(Sigma, Poole, UK), anti-phospho-histone 
H3-serine 10 antiserum (ChIP grade, 
1:200 dilution), anti-trimethyl lysine 9 
histone H3 antiserum (ChIP grade, 1:200), 
anti-acetylated lysine 14 H3 antiserum 
(Millipore, 1:200 dilution), anti-acetylated 
histone H4 (ChIP grade, 1:200 dilution), 
anti-HP1b (abcam, 1:100 dilution) - all 
antibodies from Upstate Biotechnology 
(Charlottesville, VA) unless stated. For 
detection of the MIEP of HCMV, DNA 
from disrupted nucleosomes was 
precipitated and amplified by qPCR.  
using 5′-CCA AGT CTC CAC CCC ATT 
GAC (sense) and 5′-GAC ATT TTG GAA 
AGT CCC GTT G (anti-sense) primers 
and quantified with SYBR green. Specific 
immuno-precipitation of sequences was 
expressed as enrichment from Input 
control. 
For FACS analyses, 105 cells were 
pelleted at 400g for 5 minutes and were 
then re-suspended in the residual volume. 
The cells were incubated with 3l 
Phycoerythrin (PE)-conjugated mouse 
anti-human IL-6 receptor antibody or 
fluorochrome conjugated mouse IgG1 
isotype control for 20 minutes in the dark. 
Following washing in 10 volumes of 
PBS, the cells were pelleted at 400g for 5 
minutes and were re-suspended in 500l 
of phosphate buffered saline (PBS) before 
analyzing by flow cytometry (BD 
FACScalibur or BD FACSsort). Data 
handling was performed using 
WinMDI2.9 software. All Antibodies were 
from BD Life Sciences (Franklin Lakes, 
NJ) unless stated.  
  
Nucleic acid isolation, reverse 
transcription and qPCR 
RNA was isolated from 106 cells using 
RNAeasy spin columns as described by 
the manufacturer (Qiagen, Valencia, CA). 
Following isolation, total RNA was 
incubated with DNAse I (Promega, 
Madison, WI) and then amplified by qRT-
PCR. Gene expression was quantified by 
SYBR green (Qiagen) using the following 
primer pairs: 
 IE:  5’- CAC GAC GTT CCT GCA GAC 
TAT G and 5’- CAT CCA CAT CTC 
CCG CTT AT, UL44: 5’- GTA CAA 
CAG CGT GTC GTG CT and 5’ – ATA 
ACC GCG TCA GTT TCC AC, cFOS: 5’ 
– GAA TAA GAT GGC TGC AGC CAA 
ATG GCC CGC AA and 5’ - CAG TCA 
GAT CAA GGG AAG CCA CAG ACA 
TCT , MCP-1: 5’- TGG AAT CCT GAA 
CCC ACT TC and 5’- CCC AGT CAC 
CTG CTG TTA T MCL-1: 5’-TGC AGG 
TGT GTG CTG GAG TAG and 5’-GCT 
CTT GGC CAC TTG CTT TTC, HCK: 5’ 
– CAT CAT CGT GGT TGC CCT GTA 
and 5’ – GCG GGC GAC ATA GTT GCT 
T 18S: 5’ – GTA ACC CGT TGA ACC 
CCA and 5’ – CCA TCC AAT CGG TAG 
TAG CG, MOZ sequences were amplified 
using MOZ primer set B (Santa Cruz). 
Samples were amplified using a ABI 7500 
Fast Real Time PCR machine (Applied 
Biosystems, Foster City, CA; 95oC for 15s 
and 60oC for 45s).  
 
To amplify viral DNA from naturally 
infected cells nested IE primers were used 
in a standard PCR with the following 
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cycling conditions: 95°C (5 minutes) then 
20 cycles of 94°C (1 minute), 55°C (40s) 
and 72°C (40s), and then a final extension 
at 72°C for 10 minutes. Then 5ul of this 
product was amplified under the same 
conditions for 20 cycles using nested 
primers. IE72 was amplified with sense 
primer 5'- CAT CCA CAT CTC CCG 
CTT AT-3' and antisense primer 5'- CAC 
GAC GTT CCT GCA GAC TAT G-3' 
followed by nested PCR with sense primer 
5’- GCG CCA GTG AAT TTC TCT TC 
and antisense primer 5’- ACG AGA ACC 
CCG AGA AAG ATG yielding a final 
nested product of 302bp (DNA) or 131bp 
(cDNA).  
 
Proteomic arrays 
A Phosphoproteomic array that measured 
phosphorylation of 43 human kinases 
involved in cell signaling was used as 
described by the manufacturer (RnD 
Systems, Minneapolis, MN). Briefly, 
lysates from unstimulated and IL-6 
stimulated MoDCs or MoLCs were 
incubated with the arrays for 3 hours and 
developed using ECL chemiluminescence 
and autoradiography. Pixel density was 
measured using Image J software (NIH) 
and fold change expressed from untreated 
control cells versus IL-6 treated cells. 
 
siRNA depletion of gene expression in 
DCs 
MoDCs were cultured in X-vivo 15 media 
(serum free) and then transfected with 
HCK or MOZ siRNAs using 
Lipofectamine 2000 (Invitrogen) as 
described by manufacturer. Pooled HCK 
siRNAs (Hck 4392420, Ambion) or MOZ 
siRNAs (sc-37959, Santa Cruz) were 
transfected into DCs and then KD 
confirmed 48 hours post transfection using 
gene specific primers. Controls were non-
targeting primers were obtained from the 
same supplier as the targeting siRNAs 
(Ambion and Santa Cruz). 
 
Statistical Analyses 
The Mann-U whitney test was applied to 
test for significance between the means as 
a non-parametric distribution was 
assumed. Statistical analyses were only 
applied if n>2. All scatter plots  depict the 
mean and one standard deviation from the 
mean. Significance was assumed if 
p<0.05. 
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Figure 1 IL-6 promotes distinct signalling signatures in DC subtypes a) A qRT-PCR to 
measure IE gene expression in MoDCs 16 hours post stimulation with IL-6 or two days post 
transduction with adenovirus vectors expressing constitutively active MEK or GFP control. b) 
Western blot for ERK phosphorylation in moDCs (M) or moDCs transduced with 
adenoviruses expressing GFP (Con) or constitutively active MEK c) Western blot for total 
ERK and ERK phosphorylation in MoLCs unstimulated (-) or stimulated with IL-6 (+) d) 
Flow cytometric analysis of moDCs and MoLCs stained with isotype (filled) or IL-6Ra-PE 
(line) antibodies e) Schematic of differential IL-6 response in DC subtypes f) Summary of 
differentially phosphorylated proteins in IL-6 stimulated MoDCs and MoLCs.*p<0.05 and 
**p<0.01 
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Figure 2 SFK inhibitors and HCK depletion from cells reduces reactivation in 
experimental and natural latency a) Experimentally latent MoDCs were incubated with 
media (DCs), DMSO, or SFK inhibitors PP2 and PP121 for 3 hours then stimulated with IL-6 
and analysed for IE RNA expression by qRT-PCR 16 hours later b) A qRT-PCR for c-fos 
mRNA expression was performed in unstimulated immature DCs (iDC), or iDCs pre-treated 
with PP2 or solvent control prior to IL-6 stimulation c) Naturally latent monocytes isolated 
from 2 seropositives donor were differentiated in vitro to MoDCs, pretreated with DMSO (-) 
or PP2 inhibitor (+) for 3 hours and then stimulated with IL-6 or LPS for 16 hours and cDNA 
or RNA (no RT control) analysed using a nested PCR for IE expression. d) HCK RNA 
expression was analysed in monocytes, MoDCs and MoLCs by qRT-PCR. e-g) MoDCs 
incubated with control or HCK specific siRNAs were analysed for HCK RNA expression 48 
hours post transfection (e) or stimulated with IL-6 and analysed by qRT-PCR for IE (f) or 
cellular (g) gene expression 16 hours later. *p<0.05 and **p<0.01 
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Figure 3 SFK activity is required for the formation of transcriptionally active chromatin 
at the MIEP a) ChIP assays were performed with antibodies against histone H3: 
trimethylated on lysine 9 (H3-K93me), phosphorylated on serine 10 (H3-S10P) or acetylated 
on lysine 14 (H3-K14Ac) or with an isotype control on unstimulated MoDCs (iDC) or at 2 
hours post IL-6 stimulation after prior treatment with DMSO or PP2 for 1 hour. DNA was 
amplified in an MIEP qPCR and signal expressed relative to Input (n=3). b-e) ChIP assays 
were performed 30 and 120 mins post IL-6 stimulation with antibodies against 
heterochromatin protein 1b (HP1), histone H3: trimethylated on lysine 9 (H3-K9me), 
phosphorylated on serine 10 (H3-S10P) or acetylated on lysine 14 (H3-K14Ac) or with an 
isotype control at 30 mins or 2 hours post IL-6 stimulation after prior treatment with DMSO 
or PP2 for 1 hour. DNA was amplified in an MIEP qPCR and signal expressed relative to 
Input (n=2). 
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Figure 4 HCMV reactivation is dependent on MOZ histone acetyltransferase activity 
a,b) Experimentally latent MoDCs were incubated with media (DCs), DMSO, or inhibitors of 
p300, Tip60/MOZ (MG149 75uM) or MOZ (MG149 25uM) for 3 hours then stimulated with 
IL-6 and analysed for IE (a) and UL44 (b) RNA expression by qRT-PCR 16 hours later. c c) 
Western blot for histone H3 (H3) or histone H3 acetylation on lysine 14 (H3-K14Ac) in 
DMSO (C), CPTH2 (CP) and NU9056 (Nu) treated MoDCs.d,e) MoDCs incubated with 
control or MOZ specific siRNAs were analysed for MOZ RNA expression 48 hours post 
transfection (d) or subsequently stimulated with IL-6 and analysed by qRT-PCR for IE (e) 
and UL144 gene expression 16 hours later. *p<0.05 and **p<0.01 
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Figure 5 MOZ recruitment to the MIEP is dependent on SFK signalling and is required 
for histone H4 acetylation a) ChIP assays were performed on MoDCs using antibodies 
against MOZ or an isotype control at 1 hour post IL-6 stimulation after prior treatment with 
DMSO, ERK (U0126) or SFK (PP2) inhibitors for 1 hour. DNA was amplified in an MIEP 
qPCR and signal expressed relative to Input (n=3). b) ChIP assays were performed with 
antibodies against histone H3: trimethylated on lysine 9 (H3-K9me), phosphorylated on serine 
10 (H3-S10P), and pan acetylated histone H4 on MoDCs or at 2 hours post IL-6 stimulation 
after prior treatment with DMSO, SFK (PP2) or MOZ (MG149) inhibitors for 1 hour. DNA 
was amplified in an MIEP qPCR and signal expressed relative to Input (n=2). 
 
 
 
